AAM
GHDX
Azzad Asset Management’s Genomic Health, Inc. GHDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-10,943
| Closed | -$374K | – | 317 |
|
2017
Q4 | $374K | Buy |
10,943
+136
| +1% | +$4.65K | 0.12% | 238 |
|
2017
Q3 | $347K | Buy |
10,807
+137
| +1% | +$4.4K | 0.12% | 246 |
|
2017
Q2 | $347K | Buy |
10,670
+168
| +2% | +$5.47K | 0.12% | 233 |
|
2017
Q1 | $331K | Buy |
10,502
+161
| +2% | +$5.07K | 0.12% | 227 |
|
2016
Q4 | $304K | Hold |
10,341
| – | – | 0.13% | 218 |
|
2016
Q3 | $299K | Buy |
10,341
+286
| +3% | +$8.27K | 0.12% | 222 |
|
2016
Q2 | $260K | Buy |
10,055
+182
| +2% | +$4.71K | 0.11% | 226 |
|
2016
Q1 | $245K | Sell |
9,873
-2,179
| -18% | -$54K | 0.11% | 224 |
|
2015
Q4 | $424K | Buy |
+12,052
| New | +$424K | 0.2% | 174 |
|
2015
Q3 | – | Sell |
-8,258
| Closed | -$230K | – | 262 |
|
2015
Q2 | $230K | Sell |
8,258
-61
| -0.7% | -$1.7K | 0.12% | 236 |
|
2015
Q1 | $254K | Buy |
8,319
+395
| +5% | +$12.1K | 0.12% | 242 |
|
2014
Q4 | $253K | Buy |
7,924
+376
| +5% | +$12K | 0.13% | 254 |
|
2014
Q3 | $214K | Sell |
7,548
-598
| -7% | -$16.9K | 0.12% | 272 |
|
2014
Q2 | $223K | Buy |
+8,146
| New | +$223K | 0.13% | 258 |
|